跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VILDAGLIPTINA/METFORMINA CINFA 50 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VILDAGLIPTINA/METFORMINA CINFA 50 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
VILDAGLIPTINA/METFORMINA CINFA 50 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorios Cinfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 1, 2020
Approval ID
e1e51e07a5b3384c
Company
Laboratorios Cinfa S.A.
Type
Standard
Approval Details
Approval Id
e1e51e07a5b3384c
Drug Cima Aemps Name
VILDAGLIPTINA/METFORMINA CINFA 50 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85621
Holder Company Name
Laboratorios Cinfa S.A.
Marketing Company Name
Laboratorios Cinfa S.A.
Authorization Date
2020-12-01
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 mg/850 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Cinfa S.A.
Active Ingredients
VILDAGLIPTINA
50 mg
METFORMINA HIDROCLORURO
850 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 1, 2020
Approval ID
e1e51e07a5b3384c
Type
Standard
Back to CIMA-AEMPS Approvals